Yüksel Ürün

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Yüksel Ürün
Mar 31, 2025, 11:43 | Blog
Yüksel Ürün: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, posted on X: "BREAKING…
Mar 30, 2025, 16:44 | Positive
Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Mar 27, 2025, 07:15 | Blog
Yüksel Ürün: Moderately hypofractionated radiotherapy is as effective as conventionally fractionated radiotherapy
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by…
Mar 26, 2025, 14:26 | Science
Yüksel Ürün: Revolution in Metastatic Melanoma
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by…
Mar 25, 2025, 15:24 | Societies
Highlights from 2025 EAU Annual Meeting on Urology
The 40th Annual European Association of Urology Congress (EAU 2025) was held from March 21–24,…
Mar 18, 2025, 09:46 | Blog
Yüksel Ürün: Assessing PSA after radical prostatectomy may reduce overtreatment
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a paper Derya…
Mar 18, 2025, 08:08 | Blog
Enes Erul: Insulin resistance and cancer
Enes Erul, Oncology Fellow at Ankara University, shared a post on LinkedIn about recent paper…
Mar 12, 2025, 13:02 | Blog
Yüksel Ürün: Global breast cancer cases may rise 38% by 2050
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, posted on X: "By…
Mar 11, 2025, 09:56 | Blog
March is Colorectal Cancer Awareness Month
OncoDaily joins the oncology community in raising awareness about colorectal cancer (CRC), a disease that…
Mar 11, 2025, 06:35 | Blog
Yüksel Ürün: Survey on the Prostate Cancer Care Disparity Analysis Project
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, posted on LinkedIn: "Dear…
Mar 10, 2025, 07:40 | Blog
Exploring Imposter Syndrome, Burnout, and Perfectionism Among Oncologists
Are you an oncologist? Do you sometimes feel like you don’t deserve your success? Striving…
Mar 8, 2025, 09:01 | Blog
Yüksel Ürün: Ivonescimab vs pembrolizumab in PD-L1 positive NSCLC
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Mar 4, 2025, 05:30 | Blog
Yüksel Ürün: Help us map global access to RCC, UC and PCa treatments
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Mar 1, 2025, 12:50 | Blog
Narjust Florez: Spreading Young Lung Cancer Awareness in the Dominican Republic
Narjust Florez, Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist…
Feb 27, 2025, 13:05 | Blog
Yüksel Ürün: New study shows CA-125 as a potential biomarker for RMC
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on…
Feb 25, 2025, 11:03 | Insight
Erman Akkus: Our study on Testicular Germ Cell Tumor Survivors
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about a…
Feb 25, 2025, 09:40 | Blog
Yüksel Ürün: Cancer survivors face higher risk of cardiovascular disease
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on…
Feb 25, 2025, 09:18 | Science
Yüksel Ürün: A new mRNA cancer vaccine shows promise in pancreatic cancer
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on…
Feb 25, 2025, 07:36 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Feb 23, 2025, 11:50 | Science
Yüksel Ürün: Can biopsy be omitted after a negative MRI in suspected prostate cancer?
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on…
Feb 19, 2025, 09:20 | Blog
Yüksel Ürün: Save the date for the International Urology Cancer Summit
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Feb 19, 2025, 07:46 | Blog
Yüksel Ürün: Global survey to shed light on imposter syndrome, burnout and perfectionism among oncologists
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Feb 18, 2025, 15:11 | Blog
Yüksel Ürün: Denosumab every 12 weeks vs. every 4 weeks in mCRPC
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Feb 14, 2025, 19:07 | Blog
Highlights by Yüksel Ürün from ASCO GU25 Day 1
The 2025 ASCO Genitourinary Cancers Symposium is currently taking place from February 13-15 at Moscone…
Feb 13, 2025, 07:41 | Science
Yüksel Ürün: SBRT, A powerful option for inoperable RCC
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by…
Feb 8, 2025, 19:19 | Science
Yüksel Ürün: Largest AI Mammography Trial, Game-Changer
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by…
Feb 3, 2025, 17:11 | Blog
Yüksel Ürün: Immunotherapy works in elderly, but data gaps remain
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Feb 1, 2025, 12:21 | Blog
5 articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Jan 30, 2025, 18:40 | Science
Yüksel Ürün: Understanding of Clinical Trials Among Patients With Cancer and Their Relatives
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, reshared a post by…
Jan 29, 2025, 22:14 | Blog
Yüksel Ürün: The impact of comorbidities on survival in cancer patients receiving ICIs
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine in Turkey, shared a…
Jan 21, 2025, 06:12 | Blog
Yüksel Ürün: An Excellent Overview on Systemic Therapy for Metastatic ccRCC
Yüksel Ürün, Medical Oncologist at Ankara University, posted the following on X: “An excellent overview…
Jan 18, 2025, 22:52 | Blog
Yüksel Ürün: Florence Multidisciplinary Expert Meeting on Renal Cell Carcinoma
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine in Turkey, shared a…
Jan 18, 2025, 00:00 | Science
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Jan 12, 2025, 08:00 | Blog
Implementation of AI for cancer detection in population-based mammography screening
Yüksel Ürün shared on X: "AI is HERE! In mammography screening, AI-supported double reading detects…
Jan 10, 2025, 16:26 | Science
Yüksel Ürün: Statins improve outcomes in cancer patients on ICIs
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine in Turkey, shared a …
Jan 2, 2025, 21:49 | Blog
Yüksel Ürün: Cancer could double by 2070
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine in Turkey, posted on…
Dec 29, 2024, 15:34 | Insight
Yüksel Ürün: Nature’s 10 honors those reshaping our world
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, posted on X: “Meet…
Dec 25, 2024, 13:50 | Science
Yüksel Ürün: Shaping the future of survivorship in CSI Testicular GCT
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, posted on X: "Shaping…
Dec 23, 2024, 16:19 | Insight
Michael Hofman‘s top 10 publications from 2024 which ProsTic contributed to
Michael Hofman, Nuclear Medicine Physician at Melbourne’s Peter MacCallum Cancer Centre and Director of ProsTic,…
Dec 23, 2024, 12:11 | Blog
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Dec 15, 2024, 11:42 | Science
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Dec 9, 2024, 15:08 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Dec 5, 2024, 18:41 | Blog
Yüksel Ürün: Every cancer journey is unique, but early detection saves lives
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on…
Dec 1, 2024, 21:24 | Blog
Toni Choueiri: Amazing journey all the way from Ankara to Boston and Back
Toni Choueiri, Director of the Lank Center for GU Oncology at Dana-Farber Cancer Institute, shared…
Dec 1, 2024, 16:45 | Blog
Yüksel Ürün shares his career journey and the importance of achieving a worklife-balance
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post by…
Dec 1, 2024, 15:25 | Blog
Yüksel Ürün: An honor and joy to be featured in The ASCO Post
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X:…
Nov 29, 2024, 15:42 | Blog
Yüksel Ürün: Trimodality therapy to offer hope for recurrent T1 bladder cancer after BCG failure
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X:…
Nov 28, 2024, 17:10 | Insight
Christian Rolfo: Amazing ISLB24 congress in summary
Christian Rolfo, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at…
Nov 26, 2024, 15:49 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Nov 26, 2024, 12:12 | Insight
Highlights from ISLB 2024: Exploring the Future of Liquid Biopsy
The 6th Annual Congress of the International Society of Liquid Biopsy (ISLB) took place in…
Nov 24, 2024, 17:08 | Blog
Yüksel Ürün: Liquid biopsy identifies CN losses across multiple tumor types
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on…
Nov 18, 2024, 06:37 | Blog
Yüksel Ürün: USPSTF Recommendations for Breast Cancer Screening
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Nov 15, 2024, 15:10 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Nov 13, 2024, 09:14 | Blog
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Nov 13, 2024, 09:09 | Blog
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on…
Nov 13, 2024, 08:49 | Blog
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine in Turkey, shared a…
Nov 5, 2024, 17:37 | Blog
Yüksel Ürün: 16th European Multidisciplinary Congress on Urological Cancers
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on…
Oct 27, 2024, 08:23 | Blog
Aruni Ghose: Reflecting on Cancer Real World Evidence research journey
Aruni Ghose, Internal Medicine Resident at Barts Health NHS Trust, shared a post by Stergios Boussios,…
Oct 26, 2024, 07:02 | Blog
Adolescent and young adult female cancer burden from 1990 to 2021
Yüksel Ürün shared a post on X: ''Adolescent and young adult (AYA) female cancers are…
Oct 22, 2024, 13:48 | Insight
Yüksel Ürün: Novel radiopharmaceuticals for GU cancers
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on…
Oct 16, 2024, 08:04 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Oct 11, 2024, 13:58 | Blog
Francesco Massari: Global real-world experience in mUC treatment
Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, posted…
Oct 7, 2024, 17:05 | Blog
CRISPR-based mouse model for VHL-deficient clear cell kidney cancer shows promise, suggested by Yüksel Ürün
Yüksel Ürün shared an article by Laura A Stransky on X: "A new CRISPR-based mouse…
Oct 6, 2024, 14:08 | Blog
Yüksel Ürün: Whole-pelvis radiation therapy in muscle-invasive bladder cancer
Yüksel Ürün posted on X about recent paper by Gautier Marcq et al., titled "Benefit…
Oct 5, 2024, 08:45 | Insight
Extended lymphadenectomy to increase perioperative risks in Muscle-Invasive Bladder Cancer
Yüksel Ürün posted on X: "Extended lymphadenectomy did not improve survival but increased perioperative risks in…
Oct 4, 2024, 15:07 | Blog
Yüksel Ürün: What a great meeting filled with science, fun, and friendship
Yüksel Ürün shared a post on X by Giuseppe Banna adding: "What a great meeting…
Oct 4, 2024, 06:03 | Drugs
FDA approved Neoadjuvant/Adjuvant Nivolumab for resectable NSCLC
FDA Approval Introduces New Treatment Options for Adults with Resectable Lung Cancer Lacking Key Genetic…
Oct 3, 2024, 13:00 | Positive
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
September was a significant month dedicated to raising awareness about various cancers, and Prostate Cancer…
Oct 1, 2024, 14:10 | Blog,Opinion
Yüksel Ürün: Congratulations to Aruni Ghose and team for winning the Best Poster Award
Aruni Ghose shared a post by Yüksel Ürün, on X: ''Meet URO Italy to International…
Oct 1, 2024, 14:05 | Blog
Aruni Ghose: The Right Conference at the Right Time for the Right Audience and the Right Purpose by the Right People
Aruni Ghose shared a post by Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University…
Oct 1, 2024, 04:54 | Positive
Empowering Women in Oncology: LEAD 2024 Recognized Rana McKay and Nazli Dizman
Dr. Rana McKay and Dr. Nazli Dizman were honored at the LEAD 2024 The Leadership, Empowerment,…
Sep 28, 2024, 08:24 | Blog
Sumanta K. Pal: Cannot say enough how much I learn about prostate cancer every time I hear Neeraj Agarwal
Sumanta K. Pal shared a post by Yüksel Ürün on X, adding: "Cannot say enough…
Sep 27, 2024, 13:30 | Insight
Yüksel Ürün: Adjuvant nivolumab vs placebo in localized RCC patients at high recurrence risk post-nephrectomy by Robert J. Motzer
Yüksel Ürün shared a post on X: "CheckMate 914 (Part B) failed to show DFS improvement…
Sep 20, 2024, 23:18 | Blog
Yüksel Ürun: Key goals post ESMO24
Yüksel Ürun shared a post on LinkedIn: "Key goals post ESMO24 1.Integrate findings into practice…
Sep 19, 2024, 14:33 | Insight
Prognostic Perception and Quality of Life in Patients with Metastatic Renal and Bladder Cancer
JCO Global Oncology shared a post on X: “Perceptions and Expectations: A Study on Prognostic…
Sep 19, 2024, 11:50 | Insight
Toni Choueiri: The tradition of ASCO ESMO soccer tournament
Toni Choueiri shared a post on X: “Very prepared Turkish, Swiss and Dutch - they all…
Sep 19, 2024, 08:59 | Insight
Fantastic talk by Toni Choueiri at ESMO2024 on Ti-Nivo2 trial
Petros Grivas shared a post by Yüksel Ürün on X, adding: "Fantastic talk by brilliant Toni Choueiri…
Sep 16, 2024, 13:24 | Dialogues
OncoDaily: France Bureau // vol.1
Tatev-Sargsyan Lefort presents the latest oncology news roundup from the past week, with a focus…
Sep 14, 2024, 17:15 | Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 14, 2024, 14:59 | Insight
Keeping up with Day 1 ESMO24 with Yüksel Ürün
The ESMO Congress 2024 (ESMO24) is taking place from 13-17 September 2024, in Barcelona. ESMO24…
Sep 12, 2024, 17:16 | Insight
Yüksel Ürün: Omitting the 5-FU bolus from regimens in metastatic GI cancers may reduce toxicity without impacting overall survival
Yüksel Ürün shared on X: "Omitting the 5-FU bolus from regimens like FOLFOX, FOLFIRI, and…
Sep 12, 2024, 06:03 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Sep 10, 2024, 11:25 | Blog
Cancer Care Terminology in African Languages
Yuksel Urun shared a post on X, about recent paper published in JAMA Network Open:…
Sep 7, 2024, 09:34 | Insight
How to optimize the treatment for renal cancer in real world with Yüksel Ürün - International Urology Cancer Summit
International Urology Cancer Summit shared on LinkedIn: "How to optimize the treatment for renal cancer…
Sep 6, 2024, 07:29 | Insight
Yüksel Ürün: Plant - based diet is linked to better survival in metastatic colorectal cancer
Yüksel Ürün shared a post on X: “New study suggests that a plant-based diet, especially…
Sep 2, 2024, 14:30 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Sep 1, 2024, 08:30 | Insight
Sacituzumab Govitecan in cisplatin-ineligible metastatic urothelial cancer after CPI
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic…
Aug 24, 2024, 15:10 | Blog
Yüksel Ürün: Excited to have Dr. David Gandara join us at the 6th Annual Congress on Liquid Biopsy
Yüksel Ürün shared a post by International Society of Liquid Biopsy on X: "Excited to…
Aug 24, 2024, 06:53 | Insight
Srinivas Viswanathan: A genetic basis for sex differences in Xp11 translocation renal cell carcinoma
Recently, an article by Srinivas Viswanathan et al. titled "A genetic basis for sex differences in…
Aug 23, 2024, 14:37 | Insight
Yüksel Ürün: Enzalutamide boosts OS and rPFS in mHSPC patients regardless of HSD3B1 genotype
Yüksel Ürün shared a paper by Nima Sharifi et al. on X: "Enzalutamide boosts OS…
Aug 21, 2024, 14:40 | Blog
Erman Akkus: Our review on platinum chemotherapy for metastatic castration-resistant prostate cancer
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a post on…
Aug 13, 2024, 14:52 | Insight
5 articles suggested by Yüksel Ürün
Yüksel Ürün shared a few must-reads paper on X: 1. Molecularly guided therapy versus chemotherapy…
Aug 12, 2024, 06:05 | Insight
Results suggest olanzapine should be a standard to reduce chemotherapy-induced nausea and vomiting
Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust shared a post on…
Aug 10, 2024, 12:17 | Insight
Emmanuel Antonarakis: Most compelling study suggesting that combined Abiraterone and Olaparib is better than sequential Abiraterone and Olaparib for 1st-line mCRPC
Emmanuel Antonarakis, Professor of Medicine at the University of Minnesota, shared a post on X…
Aug 10, 2024, 06:37 | Insight
Yüksel Ürün: Exploring the balance of taking breaks from chemotherapy
Yüksel Ürün shared on X: "Exploring the balance of taking breaks from chemotherapy. Can it…
Aug 7, 2024, 13:15 | Blog
The Warburg effect and how cancer metabolism affects chemotherapy response
Yüksel Ürün shared on X: "The Warburg effect drives cancer cells to metabolize glucose anaerobically, leading…
Aug 7, 2024, 01:22 | Insight
8 years of follow-up in the CheckMate 214 trial
Yüksel Ürün shared a paper by Nizar M. Tannir et al. on X: "Nivolumab +…
Aug 6, 2024, 11:06 | Blog
Yüksel Ürün: Platinum-based chemotherapy affects immune cell composition in urothelial cancer
Yüksel Ürün shared a post on X: "Platinum-based chemotherapy affects immune cell composition and tumor microenvironment…
Aug 6, 2024, 01:06 | Insight
Metastatic lung adenocarcinoma with EGFR and TP53 co-mutations shows mixed intra-patient tumor responses
Yüksel Ürün shared on X: "Metastatic lung adenocarcinoma with Epidermal Growth Factor Receptor (EGFR) and…
Aug 4, 2024, 05:26 | Blog
AACR welcomed Minorities in Cancer Research Council to headquarters for their annual summer meeting
American Association for Cancer Research - AACR shared on X: "Today we welcomed the AACR…
All: 208 Posts: 1 - 100
Special Coverage